This medicine is subject to additional monitoring. This will allow quick identification of new safety information. Any adverse events observed following the prescription of Entyvio should be reported. In the United Kingdom, adverse event reporting forms and information can be found at

Adverse events should also be reported to Takeda on 01628 537900 or e-mail